{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:11:40Z","timestamp":1757617900283,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08190-y","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T23:59:35Z","timestamp":1746748775000},"page":"3703-3707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does pre-treatment with phenobarbital prevent the acute intolerance to primidone in patients with essential tremor?"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-9034","authenticated-orcid":false,"given":"Stefano","family":"Calzetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-7612","authenticated-orcid":false,"given":"Lucia","family":"Zinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6919-5990","authenticated-orcid":false,"given":"Enrico","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-230X","authenticated-orcid":false,"given":"Anna","family":"Negrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Bottignole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-223X","authenticated-orcid":false,"given":"Emilio","family":"Perucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"8190_CR1","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/mds.27700","volume":"34","author":"JJ Ferreira","year":"2019","unstructured":"Ferreira JJ, Mestre TA, Lyons KE, Benito-Le\u00f3n J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G (2019) MDS task force on tremor and the MDS evidence based medicine committee. MDS evidence -based review of treatment for essential tremor. Mov Disord 34:950\u2013958. https:\/\/doi.org\/10.1002\/mds.27700","journal-title":"Mov Disord"},{"key":"8190_CR2","doi-asserted-by":"publisher","first-page":"l4485","DOI":"10.1136\/bmj.l4485","volume":"366","author":"V Shanker","year":"2019","unstructured":"Shanker V (2019) Essential tremor: diagnosis and management. BMJ 366:l4485. https:\/\/doi.org\/10.1136\/bmj.l4485","journal-title":"BMJ"},{"key":"8190_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1212\/wnl.41.4.602","volume":"38","author":"E Sasso","year":"1988","unstructured":"Sasso E, Perucca E, Calzetti S (1988) Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology 38:808\u2013810. https:\/\/doi.org\/10.1212\/wnl.41.4.602","journal-title":"Neurology"},{"key":"8190_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1059-1311(97)80001-5","volume":"6","author":"MJ Brodie","year":"1997","unstructured":"Brodie MJ, Dichter M (1997) Established antiepileptic drugs. Seizure 6:159\u2013174: 10.1016\/s1059-1311(97)80001-5","journal-title":"Seizure"},{"key":"8190_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","volume":"313","author":"RH Mattson","year":"1985","unstructured":"Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR et al (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. Engl J Med 313:145\u2013151. https:\/\/doi.org\/10.1056\/NEJM198507183130303","journal-title":"Engl J Med"},{"key":"8190_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/jnnp.48.9.911","volume":"48","author":"LJ Findley","year":"1985","unstructured":"Findley LJ, Cleeves L, Calzetti S (1985) Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiat 48:911\u2013915. https:\/\/doi.org\/10.1136\/jnnp.48.9.911","journal-title":"J Neurol Neurosurg Psychiat"},{"issue":"2","key":"8190_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mds.10083","volume":"17","author":"P O\u2019Suilleabhain","year":"2002","unstructured":"O\u2019Suilleabhain P, Dewey RB (2002) Jr. Randomized trial comparing primidone initiation schedules for treating essential tremor. Mov Disord 17(2):382\u2013386. https:\/\/doi.org\/10.1002\/mds.10083","journal-title":"Mov Disord"},{"key":"8190_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5334\/tohm.672","volume":"11","author":"A Lenka","year":"2021","unstructured":"Lenka A, Louis ED (2021) Primidone intolerance in essential tremor: is it more than just age? Tremor Other Hyperkinetic Movements 11:57. https:\/\/doi.org\/10.5334\/tohm.672","journal-title":"Tremor Other Hyperkinetic Movements"},{"issue":"2","key":"8190_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00007691-198406000-00010","volume":"6","author":"IE Leppik","year":"1984","unstructured":"Leppik IE, Cloyd JC, Miller K (1984) Development of tolerance to the side effects of primidone. Ther Drug Monit 6(2):189\u2013191. https:\/\/doi.org\/10.1097\/00007691-198406000-00010","journal-title":"Ther Drug Monit"},{"key":"8190_CR10","unstructured":"Bourgeois BFD, Luders H, Morris HH, Dinner D, Wyllie E, Kanner A (1989) Rapid introduction of primidone using phenobarbital loading: acute primidone toxicity avoided. Epilepsia.;30(5):667 (abstract)"},{"key":"8190_CR11","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/j.1528-1157.2000.tb04610.x","volume":"41","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Parra J, Frey M (2000) The forgotten cross-tolerance between phenobarbital and primidone: it can prevent acute primidone-related toxicity. Epilepsia 41:1310\u20131314. https:\/\/doi.org\/10.1111\/j.1528-1157.2000.tb04610.x","journal-title":"Epilepsia"},{"issue":"4","key":"8190_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/CON.0000000000000346","volume":"22","author":"ED Louis","year":"2016","unstructured":"Louis ED (2016) Diagnosis and management of tremor. Continuum 22(4):1143\u20131158. https:\/\/doi.org\/10.1212\/CON.0000000000000346","journal-title":"Continuum"},{"issue":"4","key":"8190_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1365-2125.1981.tb01274.x","volume":"12","author":"E Perucca","year":"1981","unstructured":"Perucca E, Ruprah M, Richens A, Park BK, Betteridge DJ, Hedges AM (1981) Effect of low-dose phenobarbitone on five indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects. Brit J Clin Pharmacol 12(4):592\u2013596. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01274.x","journal-title":"Brit J Clin Pharmacol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08190-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08190-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:36:28Z","timestamp":1757165788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08190-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8190"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08190-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Emilio Perucca received speaker\u2019s or consultancy fees from Eisai, SKL Life Science, Sun Pharma, Takeda, UCB Pharma and Xenon Pharma and royalties from Wiley, Elsevier, and Wolters Kluwers. Stefano Calzetti, Lucia Zinno, Enrico Sasso, Anna Negrotti and Dario Bottignole declare they have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Azienda Ospedaliero-Universitaria of Parma, Parma, Italy, approved this retrospective study. Due to difficulties involved in tracking patients and anonymization of data for analysis, informed consent was waived and deemed unnecessary for this work. We confirm that we have read the journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent"}}]}}